Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Introduction to Language of Pathophysiology l01:25

Introduction to Language of Pathophysiology l

Pathophysiology investigates how biological mechanisms—typically starting at the cellular level—disrupt normal bodily functions. It bridges anatomy and physiology to explain the progression of disease. With this foundation, it is important to understand the following key terms used to describe disease processes: Diagnosis:The process of identifying a disease using clinical evaluation, including signs (objective evidence like rashes), symptoms (subjective experiences like pain), laboratory test...
Introduction to Language of Pathophysiology ll01:17

Introduction to Language of Pathophysiology ll

This lesson explores key terms that describe how diseases progress, their outcomes, and their distribution in populations.Diagnostic tests identify diseases and monitor treatment. These include blood and urine tests, biopsies, imaging (X-ray, MRI), and detection of infectious agents.Remission is a reduction or disappearance of symptoms.Exacerbation refers to the worsening of symptoms, such as increased wheezing during an asthma attack.A precipitating factor triggers an acute episode, while a...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Editorial: Ocular surface disorders- an insight.

Frontiers in ophthalmology·2026
Same author

Subclinical Venous Injury in Transvenous Lead Extraction: Histological Correlation With Clinical Risk Factors.

Journal of cardiovascular electrophysiology·2026
Same author

Multi-Omics Study of Ancestry in Adults with Intracranial Cancers - Glioma (MOSAIC).

bioRxiv : the preprint server for biology·2026
Same author

Ibandronate Use in Osteoporotic Vertebral Fractures: A Retrospective Clinical Study Integrated with Exploratory Network Pharmacology and Cross-Cohort Transcriptomic Analysis.

Biomedicines·2026
Same author

Treatment of Isocitrate Dehydrogenase-Mutant Gliomas.

Advances in oncology·2026
Same author

Time Is Key: Early Diagnosis of Post-Transplant Lymphoproliferative Disorder Presenting as Primary CNS Diffuse Large B-Cell Lymphoma.

Current oncology (Toronto, Ont.)·2026

Related Experiment Video

Updated: May 28, 2026

Introduction of an Integrated Pathology Image Management, Artificial Intelligence, and Reporting System
05:33

Introduction of an Integrated Pathology Image Management, Artificial Intelligence, and Reporting System

Published on: July 11, 2025

Pathology Foundation Models: Evolution, Current Landscape, Challenges and Opportunities from a Technical and Clinical

Hussien Al-Asi1,2, Ibrahim Yilmaz1,2, Jordan Reynolds1

  • 1Department of Laboratory Medicine and Pathology, Mayo Clinic Florida, 4500 San Pablo Rd S, Jacksonville, FL 32224, USA.

Bioengineering (Basel, Switzerland)
|May 27, 2026
PubMed
Summary

Pathology Foundation Models (PFMs) offer scalable, adaptable representations of whole-slide images for diagnostics. Future development requires rigorous benchmarking and multimodal integration for clinical translation.

Keywords:
artificial intelligencedeep learningpathology foundation modelsvision encodersvision transformers

More Related Videos

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
09:29

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on: September 30, 2016

Related Experiment Videos

Last Updated: May 28, 2026

Introduction of an Integrated Pathology Image Management, Artificial Intelligence, and Reporting System
05:33

Introduction of an Integrated Pathology Image Management, Artificial Intelligence, and Reporting System

Published on: July 11, 2025

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
09:29

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on: September 30, 2016

Area of Science:

  • Computational pathology
  • Artificial intelligence in histopathology
  • Foundation models in medicine

Background:

  • Foundation models (PFMs) are revolutionizing computational pathology with scalable, task-agnostic representations of whole-slide images (WSIs).
  • PFMs utilize self-supervised Vision Transformer architectures and large WSI datasets for broad generalization and few-shot learning.
  • The field has evolved from earlier methods like CLAM and HIPT to large-scale models such as UNI, Virchow, Phikon, CONCH, GigaPath, H-Optimus, TITAN, and the Mayo Clinic Atlas.

Purpose of the Study:

  • To review the development of PFMs in computational pathology.
  • To critically evaluate the strengths and limitations of current PFMs.
  • To outline priorities for the safe and effective clinical translation of PFMs.

Main Methods:

  • Review of existing literature on pathology foundation models.
  • Analysis of PFM performance across diagnostic and prognostic benchmarks.
  • Evaluation of multimodal integration capabilities with genomics and clinical data.

Main Results:

  • PFMs demonstrate impressive performance and enable multimodal data integration.
  • Significant barriers include inconsistent institutional generalization, lagging interpretability, and slow workflow integration.
  • Specific areas like cytopathology and rare tumor subtypes remain challenging for current models.

Conclusions:

  • The next phase of PFM development necessitates rigorous benchmarking and pathologist-in-the-loop deployment.
  • Multimodal fusion is crucial for advancing PFMs from research tools to clinically robust systems.
  • Addressing limitations in generalization, interpretability, and workflow integration is key for clinical translation.